跳至主要内容
临床试验/ISRCTN54376151
ISRCTN54376151已完成不适用

Methotrexate In Psoriatic Arthritis

Arthritis Research Campaign (ARC) (UK)0 个研究点目标入组 0 人开始时间: 2002年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with psoriatic arthritis currently attending specialist rheumatology clinics and with active peripheral synovitis.

排除标准

  • Not provided at time of registration

研究者

发起方
Arthritis Research Campaign (ARC) (UK)

相似试验

已完成
4 期
In methotrexate resistant rheumatoid arthritis, switching methotrexate to tofacitinib versus adding tofacitinib to methotrexate, open labeled, multicenter randomized non-inferiority study.Rheumatoid arthritis
JPRN-UMIN000017440Graduate School of Medicine and School of Medicine, Chiba University the department of allergy and clinical immunology134
已完成
3 期
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase
NL-OMON22681Sint Maartenskliniek Nijmegen100
进行中(未招募)
1 期
A randomized placebo-controlled trial to investigate clinical efficacy and safety of methotrexate in erosive inflammatory hand osteoarthritis.orwegian adult males and females with symptomatic erosive inflammatory hand osteoarthritis.MedDRA version: 21.1Level: LLTClassification code 10016686Term: Finger osteoarthritisSystem Organ Class: 100000004859MedDRA version: 21.1Level: LLTClassification code 10019115Term: Hand osteoarthritisSystem Organ Class: 100000004859MedDRA version: 21.0Level: LLTClassification code 10064565Term: Erosive osteoarthritisSystem Organ Class: 100000004859
EUCTR2019-004641-33-NODiakonhjemmet Hospital210
进行中(未招募)
1 期
The MERINO trialErosive hand osteoarthritisMedDRA version: 21.1Level: LLTClassification code: 10019115Term: Hand osteoarthritis Class: 10028395
CTIS2023-510523-30-00Diakonhjemmet Sykehus AS153
招募中
4 期
Discontinuation of methotrexate in rheumatoid arthritis patients achieving clinical remission by treatment with upadacitinib plus methotrexate (DOPPLER study): Study protocol for an interventional, multicenter, open-label and single-arm clinical trial with clinical, ultrasound and biomarker assessmentsRheumatoid arthritis
JPRN-jRCTs071200079Kawakami Atsushi155